ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 647117 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 647117; 2) Community: the network communities that were significantly associated with the response to NSC 647117; 3) Molecule: the relationships between components within communities and NSC 647117; 4) MDR: the compounds that were significantly associated with the NSC 647117.

NSC Compound Enrichment Correlation
NSC 708416 Null 0.0152777849043084 0.24861589
NSC 709100 Null 0.0152777849043084 0.28169743
NSC 744020 methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate 0.0152777849043084 0.32599897
NSC 746513 5-Triazol-2-yl-methyl-2-[2?,(2??-chlorophenyl)-thiazolidin-4?-one-3?-yl]-1,3,4-oxadiazole 0.0152777849043084 0.16115165
NSC 136722 Paucin 0.0152777849043087 0.20429329
NSC 278632 Null 0.0152777849043087 0.23378999
NSC 2805 2,2',5,5'-Tetrahydroxy-4,4'-dimethylbiphenyl 0.0152777849043087 0.13736694
NSC 352122 Trimetrexate glucuronate 0.0152777849043087 0.20407965
NSC 617823 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride 0.0152777849043087 0.17589703
NSC 623436 TGF.alpha.-PE40 0.0152777849043087 -0.27783894
Total:110  Current:43    [First] [Prev] [Next] [Last]